Mexico's health ministry reported 149 new confirmed deaths from COVID-19, according to data released on Thursday, bringing the official death toll since the pandemic began to 298,508.
The ministry has previously said the real number of victims of the coronavirus pandemic is likely significantly higher.Reporting by Diego Ore Editing by Chris ReeseSubscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
U.S. Life Expectancy Dropped Nearly 2 Years in 2020COVID-19 fueled the largest single-year increase in annual U.S. deaths on record
Weiterlesen »
India's staggering COVID-19 death toll could be 6 million: StudyNew research suggests that India’s COVID-19 death toll during its first and second waves might have been significantly undercounted, with the actual number potentially 12 times higher than the official stats — over 6 million people.
Weiterlesen »
Omicron variant that may resist vaccines found in all U.S. statesWhile cases have largely been mild, officials are warning against underestimating the COVID-19 variant.
Weiterlesen »
Life Expectancy in U.S. Declined 1.8 Years in 2020, CDC SaysNew federal figures show a deeper than previously reported decline in U.S. life expectancy last year, as the Covid-19 pandemic took hold
Weiterlesen »
Covid-19 was third leading cause of death in 2020, driving a record increase in death rateCovid-19 claimed hundreds of thousands of lives in the United States in 2020, driving a record increase in the death rate and a drop in life expectancy of nearly two years, according to final 2020 death data from the US Centers for Disease Control and Prevention's National Center for Health Statistics.
Weiterlesen »
FDA authorizes second antiviral pill to treat Covid-19The US Food and Drug Administration on Thursday authorized Merck's antiviral pill, molnupiravir, to treat Covid-19 'for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate.'
Weiterlesen »